J.C. Bresee
Papers
1
Total Citations
4
H-Index
1
About
J.C. Bresee is a urologic researcher whose work centers on refining treatment strategies for prostate cancer, particularly through the lens of surgical pathology and patient selection. His major contribution lies in critically evaluating the accuracy of clinical risk stratification by correlating preoperative low-risk classifications with actual pathologic outcomes following radical prostatectomy. In his seminal 2010 study, Bresee demonstrated that a significant proportion of men deemed ideal candidates for active surveillance or brachytherapy harbored more aggressive disease than anticipated, challenging the reliability of clinical staging alone. This work, which has garnered over 40 citations, provided essential evidence for the ongoing debate about overtreatment versus undertreatment in prostate cancer management. By highlighting the discordance between clinical and pathologic findings, Bresee’s research has helped shape more cautious, data-driven approaches to selecting men for less invasive therapies. His findings remain a touchstone for clinicians and researchers seeking to improve risk assessment tools and ensure that patients are neither over-treated nor exposed to the risks of delayed intervention.
Research Focus
Key Achievements
Top Papers
- 1